NCT07254858 2025-11-28
CISN-L
First Affiliated Hospital of Wenzhou Medical University
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT06308939 2024-03-13
Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial
Zhejiang Cancer Hospital
Phase 2 Not yet recruiting
NCT05386524 2023-02-16
Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC
Fudan University
Phase 2 Unknown